Aridis Pharmaceuticals, Inc.
ARDS · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $22 | $29 | $56 | $38 |
| - Cash | $5 | $20 | $8 | $21 |
| + Debt | $6 | $6 | $1 | $0 |
| Enterprise Value | $23 | $15 | $48 | $17 |
| Revenue | $0 | $0 | $1 | $1 |
| % Growth | – | -100% | -2.2% | – |
| Gross Profit | $0 | $0 | $1 | $1 |
| % Margin | – | – | 100% | 100% |
| EBITDA | -$30 | -$44 | -$22 | -$29 |
| % Margin | – | – | -2,206.4% | -2,813% |
| Net Income | -$31 | -$42 | -$22 | -$30 |
| % Margin | – | – | -2,233.3% | -2,904.2% |
| EPS Diluted | -1.64 | -3.44 | -2.44 | -3.43 |
| % Growth | 52.3% | -41% | 28.9% | – |
| Operating Cash Flow | -$29 | -$23 | -$20 | -$8 |
| Capital Expenditures | -$0 | -$1 | -$0 | -$0 |
| Free Cash Flow | -$29 | -$23 | -$21 | -$8 |